Menu

Sea Anemone Toxin Could Treat Autoimmunity

If successful, the treatments could alleviate patients’ pain by reducing inflammation.

Jan 1, 2018
Jef Akst

© ISTOCK.COM/DAMOCEANIn the early days of searching for interesting compounds in animal venoms, researchers regularly discovered molecules that blocked voltage-gated sodium channels. While these channels play critical roles in pain perception, the protein family that makes up the channels also mediates other physiological functions, so the challenge became to block channels only on cells involved in pain. “It’s all about selectivity,” says Christine Beeton, an immunologist at Baylor College of Medicine.

In the mid-1990s, researchers discovered an alternative—stichodactyla toxin (ShK) from a Caribbean sea anemone (Stichodactyla helianthus), one of the first peptide toxins identified that blocks a voltage-gated potassium channel. And not just any potassium channel; ShK targets KV1.3, which is upregulated on autoreactive T lymphocytes—cells that drive numerous autoimmune diseases, Beeton explains. “That makes this channel a very, very good target, because now you can target autoreactive T lymphocytes without targeting all the T lymphocytes in the body, so you’re not completely immunocompromising the patients.”

In 2001, Beeton started working on ShK as a postdoc at the University of California, Irvine. There she helped develop the analog ShK-186—so called because it was the 186th compound tested—which was highly selective for the KV1.3 channel and bound to it with a high affinity. Now known as dalazatide, the drug is being developed by Seattle-based Kineta for the treatment of multiple autoimmune disorders, including psoriasis (the only indication for which dalazatide has progressed to early-stage human trials), inclusion-body myositis, and lupus. While dalazatide is not an analgesic per se, “each time you have an inflammatory disease, if you manage to reduce this inflammation, as an effect you’re going to reduce pain also,” Beeton says.

Read about other animal groups researchers are exploring for pain-killing leads in the full feature story, “Animal Analgesics.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.